JANET HEWITT: Open Payments
NPI 1912488123 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 24 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $261 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Boston Scientific Corporation | 2 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VYNDAQEL, Kerendia, WATCHMAN FLX, ELIQUIS, ENTRESTO, OPSYNVI, LEQVIO.
Industry payments across CA — which companies pay providers there.
